Skip to content

Clinical research of the left ventricular assist device with post-auricular connector

Clinical research of the left ventricular assist device with post-auricular connector - Clinical research of Jarvik-PA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000025211
Enrollment
6
Registered
2017-02-01
Start date
2017-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe heart failure

Interventions

The study will utilize the Jarvik 2000 LVAS with Post- Auricular Connector in patients with New York Heart Association Class IIIb and IV end-stage left ventricular failure who are ineligible for cardi

Sponsors

Osaka University hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) patient who understands the purpose of the study and consents the entry. 2) 20 years old or older. 3) patient and his family understand and consent end-of-life care. 4) severe heart failure patient who needs heart transplantation but is ineligible for it. 5) New York Heart Association Class IIIb and IV end-stage left ventricular failure. 6) patient who has undergone maximum optimal medical therapy but has been demonstrated to be refractory to it. 7) BSA 1.2-2.3m2 8)patient who has a care-giver.

Exclusion criteria

Exclusion criteria: 1) J-macs profile 1 2) patients who have uncontrollable severe infections. 3) the prognosis of other diseases is less than 3 years. 4) patients who underwent open chest surgery less than 2 weeks before. 5) patients who has contraindication of LVAD implantation due to aortic or ventricular aneurysm, or VSD etc(exclude the cases who can undergo the surgery at the same time). 6) patients who has moderate AR (exclude the cases who can undergo the surgery at the same time). 7) patients with severe cerebral or phsychological disease who can't control LVAD. 8) patients who has a tendency to bleed. 9) pregnant or who wants to became pregnant 10)cirrhosis (Child C) 11) patients who refuse transfusion. 12) patients who has an allergy to bovine products. 13) patients who are participating other clinical studies which affects this study. 14) patients who are considered to be inappropriate to join this study by the researcher.

Design outcomes

Primary

MeasureTime frame
Drive-line infection 6-month after the implantation

Countries

Japan

Contacts

Public ContactRyohei Matsuura

Osaka University hospital Department of Cardiovascular Surgery

r-matsuura@surg1.med.osaka-u.ac.jp0668793154

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026